Skip to main content

Table 2 Patient characteristics by initial therapy

From: Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients

Characteristic

Echinocandin

Fluconazole

P

(n = 315)

(n = 374)

Antifungal exposure in preceding 30 days

164 (52%)

143 (38%)

<.001

 Triazole exposure

92 (29%)

127 (34%)

.19

 Echinocandin exposure

90 (29%)

15 (4%)

<.001

Empiric therapy

47 (15%)

52 (14%)

.74

Delay between culture and treatment, days

2.5 ± 1.4

2.2 ± 1.4

.033

Months since PATH registry opened

26 ± 11

23 ± 12

<.001

Initial therapy changed by day 2

35 (11%)

90 (24%)

<.001

Initial therapy changed by day 6

98 (31%)

121 (32%)

.74

  1. Values are n (%) or mean ± SD.